Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
10/2006
10/03/2006US7115654 Caspase-1 inhibitors and methods for their use
10/03/2006US7115652 Aspartyl protease inhibitors
10/03/2006US7115618 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
10/03/2006CA2189221C Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them
10/03/2006CA2167718C Synthesis of taxol and its derivatives
09/2006
09/28/2006WO2006102387A1 Improved process for preparing insecticidal (disubstitutedpropenyl) phenylalkyl substituted dihydrobenzofurans
09/28/2006WO2006100922A1 Cinnamoyl compound and use thereof
09/28/2006WO2006100519A1 Arylsulfonyl benzofused heterocycles as 5-ht2a antagonists
09/28/2006WO2006100502A1 11-beta-hydroxysteroid dehydrogenase inhibitors
09/28/2006WO2006100479A1 Methods for the synthesis of heteroaromatic compounds
09/28/2006WO2006100289A1 Method for producing alkoxylated 2,5-dihydrofuran but-2-ene derivatives or tetra-1,1,4,4-alkoxylated but-2-ene derivatives
09/28/2006WO2006055725A3 Substituted amino acids as protein tyrosine phosphatase inhibitors
09/28/2006WO2006047503A3 Inhibitors of c-fms kinase
09/28/2006WO2006044975A3 Compositions and their use as anti-tumor agents
09/28/2006WO2005119315A3 Non-linear optically active molecules, their synthesis, and use
09/28/2006WO2005064008A9 Method and compositions for identifying anti-hiv therapeutic compounds
09/28/2006US20060217570 Novel Tertiary Amine Compounds Having An Ester Structure And Processes For Preparing The Same
09/28/2006US20060217433 Sulfonamide derivatives as ppar modulators
09/28/2006US20060217426 Compound inhibiting in vivo phosphorous transport and medicine containing the same
09/28/2006US20060217421 Fortifier
09/28/2006US20060217372 Diaryl ethers as opioid receptor antagonist
09/28/2006US20060217310 Fibroblast growth factor 1 (FGF-1) used for skin care
09/28/2006DE102005013631A1 Verfahren zur Herstellung von alkoxylierten 2,5-Dihydrofuran- oder tetra-1,1,4,4-alkoxylierten But-2-enderivaten A process for the production of alkoxylated 2,5-dihydrofuran or tetra-1,1,4,4-but-2-alkoxylated enderivaten
09/28/2006CA2602077A1 Method for producing alkoxylated 2,5-dihydrofuran but-2-ene derivatives or tetra-1,1,4,4-alkoxylated but-2-ene derivatives
09/28/2006CA2601000A1 Arylsulfonyl benzofused heterocycles as 5-ht2a antagonists
09/28/2006CA2599794A1 Cinnamoyl compound and use thereof
09/28/2006CA2598589A1 11-beta-hydroxysteroid dehydrogenase inhibitors
09/27/2006EP1705179A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists
09/27/2006EP1705167A1 Process for the catalytic oxidation of hydrocarbons
09/27/2006EP1704856A1 Hsp90 family protein inhibitor
09/27/2006EP1704139A1 DISUBSTITUTED CHALCONE OXIMES AS SELECTIVE AGONISTS OF RAR y RETINOID RECEPTORS
09/27/2006EP1532127B1 PREPARATION OF STEREOISOMERS OF (3ALPHA, 3ALPHA/BETA, 6ALPHA/BETA) HEXAHYDROFURO(2,3-b) FURAN-3-OL
09/27/2006EP1383757B1 Antagonists of mcp-1 function and methods of use thereof
09/27/2006CN1839145A Steroid spirolactonization
09/27/2006CN1837200A Tanshinone I derivatives and pharmaceutical application thereof
09/27/2006CN1837199A Tanshinone I derivatives and pharmaceutical application thereof
09/27/2006CN1837198A Tanshinone IIA derivatives and pharmaceutical application thereof
09/27/2006CN1837197A Salvianolic acid M and rosmarinic acid as aldose reductase inhibitor in sage
09/27/2006CN1837194A Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
09/26/2006US7112686 Precipitation from mother liquors by adding bases or acid addition salts to solution of citalopram
09/26/2006US7112594 A N-phenyl-benzo(b)thiophene-carboxamide derivatives, as enzyme inhibitor of tyrosine kinase; antiproliferation of lymphocyte, treating autoimmune disease, rheumatic disease, as immunosuppressant, antiinflammatory agents
09/26/2006US7112586 Substituted diamine derivatives useful as motilin antagonists
09/21/2006WO2006098355A1 Anticancer compound, intermediate therefor, and processes for producing these
09/21/2006WO2006098308A1 Novel anthranilic acid derivative or salt thereof
09/21/2006WO2006096911A1 Novel potassium channel blockers and uses thereof
09/21/2006WO2005037207A3 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms)
09/21/2006US20060211860 Compounds for the treatment of Alzheimer's disease
09/21/2006US20060211675 Preventives/remedies for urinary disturbance
09/21/2006US20060211656 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
09/21/2006US20060211107 Protease inhibitor conjugates and antibodies useful in immunoassay
09/21/2006CA2602609A1 Novel anthranilic acid derivative or salt thereof
09/20/2006EP1702912A1 Remedy
09/20/2006EP1701953A1 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
09/20/2006EP1701947A2 4-oxo-4,5-dihydro-furan-2-carboxylic and acid derivatives and methods of treatment of metabolic-related disorders thereof
09/20/2006EP1701946A2 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
09/20/2006EP1200081B1 Use of escitalopram for the treatment of generalised anxiety disorder
09/20/2006EP0889889B1 Piperazine and piperidine compounds
09/20/2006CN1276001C Method for producing polytetrahydrofurane having a low color indices
09/20/2006CN1275969C Application of active ingredient of coumarin category distilled from dahurian angelica in preparing medicine for curing high blood pressure and its extracting method
09/20/2006CN1275953C Retinol derivatives and cosmestics composition containing the same
09/20/2006CN1275596C Application of probuco monoester intreating amgiocardiopathy and inflammatry disease
09/19/2006US7109377 Synthesis of combinatorial libraries of compounds reminiscent of natural products
09/19/2006US7109371 Prostaglandin synthesis
09/19/2006US7109357 Making 3-amido-5-oxy-furan-2-one derivatives by aziding a butenlactone, converting to an amino or an iminophosphorane and coupling with an acid; caspase inhibitors
09/19/2006US7109327 Oxidizing agent mixed with a support starting from 8-methoxy-3,4,4a,8a-tetrahydro-spiro-chromen-2-one-[4,4']-cyclohex-2',5'-dien-1'-one to a spirodienone yields 1.6 (+-)-11-oxonarwedine or (+-)-6-methoxy-10-methyl-galantham-1-ene-3,11-dione; treating Alzheimer's disease
09/19/2006US7109243 Inhibitors of cathepsin S
09/19/2006US7109239 for oral administration using sustained release dosage forms; baclofen and baclofen analogs
09/19/2006US7109232 Compounds from Antrodia camphorata having anti-inflammatory and anti-tumor activity
09/19/2006US7109230 Resistance-repellent retroviral protease inhibitors
09/19/2006US7109150 Preventing infestation of plants by phytopathogenic microorganisms; horticulture, agriculture
09/19/2006US7108987 Factors participating in degranulation of mast cells, DNAs encoding the same, method of screening of these factors and the inhibitors
09/19/2006CA2255664C Selenophene anti-tumor agents
09/14/2006WO2006096564A1 Fused aromatic compounds having anti-diabetic activity
09/14/2006WO2006095568A1 Process for oxidation of organic compounds
09/14/2006WO2006095020A1 Heterocyclic-substituted alkanamides useful as renin inhibitors
09/14/2006WO2006094842A1 Acylated piperidihes as glycine transporter inhibitors
09/14/2006WO2006094456A1 An extract of styrax linn, the preparation and uses thereof
09/14/2006WO2006094395A1 Preparation of acid addition salts of amine bases by solid phase-gas phase reactions
09/14/2006WO2006063287A3 Conversion of 2,5-(hydroxymethyl) furaldehyde to 2,5-bis (hydroxymethyl) tetrahydofuran, purification and industrial uses of the product
09/14/2006WO2005037257A3 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
09/14/2006US20060205961 Amidating 5-halo-3-nitrosalicylic acid, catalytically hydrogenating the nitro group to form the amine, and reacting the amine with 3,4-dialkoxy-1,2-cyclobutenedione
09/14/2006US20060205960 2-Oxabicyclo[3.3.0]octane compounds, process for producing the same, optical resolver, method of separating diastereomer mixture, and method of optically resolving alcohol
09/14/2006US20060205957 Process for producing vinyl ether compounds
09/14/2006US20060205817 Method for preparing 4-hydroxyisoleucine diastereoisomers and enantiomers and derivatives thereof
09/14/2006US20060205808 Anti-inflammatory and cure for ageing, Alzheimer's disease on phloroglucinol derivatives
09/14/2006US20060205772 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type I
09/14/2006US20060205751 Novel compounds
09/14/2006US20060205739 Aroylfuranes and aroylthiophenes
09/14/2006US20060205732 Nonphytotoxic; 4-Bromo-3-methoxy-N-4-[4(trifluoromethyl)phenoxy]phenyl-thiophene-2-carboxamide; 4-[(Allyloxycarbonyl)amino]-3-methoxy-N-4-[4-(trifluoromethyl)phenoxy]phenyl-thiophene-2-carboxamide
09/14/2006US20060205632 Pro-fragrance and pro-flavorant compositions
09/14/2006US20060204871 Organic photoconductive material and, using the same, electrophotographic photoreceptor and image forming device
09/14/2006US20060204587 Use of film coating as taste-masking coating of oral dosage forms
09/14/2006CA2600674A1 Heterocyclic-substituted alkanamides useful as renin inhibitors
09/14/2006CA2597120A1 Methods for oxidizing organic compounds
09/13/2006EP1701507A1 A method and system for a low-overhead mobility management protocol in the internet protocol layer
09/13/2006EP1700851A1 Crystalline citalopram diol intermediate alkali
09/13/2006EP1700844A1 Phthalic acid diamide derivatives, agricultural and horticultural insecticides and a method for application of the insecticides
09/13/2006EP1699773A2 Processes for preparation of crystalline mycophenolate sodium
09/13/2006EP1699772A1 Process for the preperation of n-alkyl-2(hydroxy-4 benzoyl)-3 benzofurans and its intermediates thereof
09/13/2006EP1699771A1 A process for the liquefaction of lignocellulosic material